Skip to content

Usefulness of Calprotectin for Colon Adenoma Screening

Usefulness of Fecal Calprotectin for Screening Colon Adenoma in Korean Population

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01719198
Enrollment
500
Registered
2012-11-01
Start date
2012-10-31
Completion date
Unknown
Last updated
2012-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Adenoma

Keywords

adenoma, calprotectin

Brief summary

The fecal calprotectin assay is used widely for inflammatory bowel disease diagnosis and the assessment of the disease activity. Some adenoma patients have elevated fecal calprotectin level, which could mean the role of fecal calprotectin as a screening marker for colon adenoma. We will investigate the usefulness of fecal calprotectin as colon adenoma marker for screening in this study.

Interventions

None listed

Sponsors

Konkuk University Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* over 18 years old adult population

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frame
fecal calprotectin level1 day (at the hospital visit)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026